Notable Health
Healthcare AI platform for patient engagement and staff workflow automation — the Notable platform is deployed at 12,000+ sites of care, 32M+ patients and 1.4M+ tasks daily across the customer base (Intermountain Health, MUSC Health, North Kansas City Hospital, CityMD and others), automating workflows across scheduling, registration, intake, referrals and prior authorizations.
The Business
Notable Health is a healthcare AI platform for patient engagement and staff workflow automation founded in 2017 by Pranay Kapadia (CEO), Adam Ting (CPO) and Justin White, PhD (CTO). The platform is positioned as “the leading automation platform for patient engagement and staff workflows” per the company’s own coverage, deployed at 12,000+ sites of care automating 1.4M+ tasks every day across scheduling, registration, intake, referrals and prior authorizations. The product line spans the original Notable workflow-automation platform, the Flow AI conversational assistant that converts the platform into an agentic-workflow surface, and the next-generation Flow Builder that expands AI-powered automation into broader healthcare administrative use cases. The company is privately held; cumulative external capital is approximately $120M+ across multiple rounds anchored by the November 2021 ICONIQ-Growth-led $100M Series B at a $600M post-money valuation per Notable’s own announcement and TechCrunch coverage. Notable has achieved Oracle Validated Integration with Oracle Health and is deployed at Epic-anchored health systems including Intermountain Health and Medical University of South Carolina.
Customers and Distribution
Notable Health is deployed at 12,000+ sites of care including marquee health-system references Intermountain Health, Medical University of South Carolina (MUSC Health), North Kansas City Hospital, CityMD (multi-year partnership announced 2025) and Inova Health (welcome announcement 2025 per Pranay Kapadia LinkedIn coverage). The company does not separately disclose ARR, revenue or named-customer counts beyond the named-press references; the November 2021 ICONIQ-Growth-led $100M Series B at $600M valuation is the most-recent material commercial-trajectory disclosure on the public record. Distribution sits across three channels: direct enterprise sales for the health-system customer base; EHR-integration channels through Oracle Health (Oracle Validated Integration) and Epic deployment depth; and the customer-success motion driving expansion across the existing 12,000+ sites-of-care cohort. The Flow AI conversational-assistant and Flow Builder product cycle is positioned as the conversion driver toward agentic workflow automation across the existing customer base.
Model Strategy
Notable Health’s strategic model is healthcare-vertical-specific intelligent automation. The platform combines proprietary workflow-automation primitives (the original Notable platform anchoring scheduling, registration, intake, referrals and prior-authorization workflows) with foundation-model-powered conversational AI (Flow AI as the conversational-assistant layer) and the next-generation Flow Builder that converts the platform into an agentic-workflow surface for healthcare administrative use cases. The strategic differentiator is healthcare-vertical depth: Notable is purpose-built for the patient-engagement-and-staff-workflow surface across health-system administrative operations rather than as a horizontal RPA platform or as an ambient-scribe clinical-documentation product. The supplier strategy is multi-model foundation-model routing for Flow AI; the platform strategy is the EHR-integration depth (Oracle Validated Integration with Oracle Health, Epic deployment depth) that lets Notable run alongside the EHR rather than competing with it; the data strategy is the healthcare-administrative-workflow corpus as the vertical-depth moat.
Leadership Team
Notable Health is privately held; founders Pranay Kapadia (CEO), Adam Ting (CPO) and Justin White, PhD (CTO) remain in place from the founding through the November 2021 Series B. Senior recruiting has concentrated on the clinical-medical-officer tier (Neinstein) and on health-system GTM through the customer-base build-out across the 12,000+ sites of care, 32M+ patients and 1.4M+ tasks daily. The company’s careers page is the canonical entry point for senior team disclosure. The IM Auditor 2026-06-02 fact-check removed an earlier draft entry incorrectly listing Muthu Alagappan as a co-founder; per Notable’s own about page the correct founding team is Pranay Kapadia (CEO), Adam Ting (CPO) and Justin White, PhD (CTO), with Aaron Neinstein as Chief Medical Officer.
Funding History
| Date | Round | Raised | Post-money | Lead investor(s) |
|---|---|---|---|---|
| Nov 2021 | Series B | $100M | $600M | ICONIQ Growth (with Greylock, F-Prime Capital, Oak HC/FT) |
| 2020 | Series A | ~$13M reported | — | Greylock Partners (with F-Prime Capital, Oak HC/FT, Maverick Ventures, 8VC) |
Cumulative external capital approximately $120M+ across multiple rounds per consolidated coverage. Headline round is the November 2021 ICONIQ-Growth-led $100M Series B at a $600M post-money valuation per Notable’s own announcement and TechCrunch coverage. Investor cohort includes ICONIQ Growth, Greylock Partners, F-Prime Capital, Oak HC/FT, Maverick Ventures and 8VC. No new priced round has been publicly disclosed at time of writing post the November 2021 Series B.
Competitive Landscape
| Competitor | Positioning | Distribution edge | Threat profile |
|---|---|---|---|
| Abridge | Ambient clinical scribe for the physician-encounter surface; category-leader brand at ~30% share per Menlo Ventures, with the $5.3B Series E led by a16z anchoring the procurement frame. | Direct US health-system salesforce plus deep Epic-marketplace integration; named customer roster spans Kaiser Permanente, Sutter Health, Mayo Clinic and UCI Health. | High — flanking on clinical documentation — the ambient-scribe healthcare-AI category leader at ~30% market share per Menlo Ventures coverage, with a 2025 Series E led by Andreessen Horowitz at ~$5.3B valuation. Less direct on patient-engagement-and-staff-workflow automation but credible flanking risk on the broader healthcare-AI procurement budget. |
| Ambience Healthcare | Ambient clinical scribe positioned as the multi-specialty AI documentation platform; ~13% share per Menlo Ventures with co-leads a16z and Oak HC/FT on the July 2025 Series C at $1.25B. | Direct US health-system sales plus Epic-marketplace integration; reference customers include Cleveland Clinic and UCSF Health on the academic-medical-centre segment. | High — flanking on clinical documentation — ambient-scribe peer at ~13% market share per Menlo Ventures, with a July 2025 Series C at $1.25B valuation co-led by Andreessen Horowitz and Oak HC/FT. Same flanking dynamic on the broader healthcare-AI procurement budget. |
| Microsoft Nuance DAX Copilot ((Microsoft)) |
Ambient clinical documentation inside Microsoft 365 and Dragon Medical One; the incumbent at ~33% share per Menlo Ventures, distributed through Microsoft enterprise healthcare procurement. | Microsoft enterprise healthcare channel plus the Nuance Dragon installed base across hundreds of US health systems; bundled-licence motion into existing Microsoft contracts. | High — incumbent on documentation — the healthcare-AI incumbent at ~33% market share per Menlo Ventures coverage; distribution moat through Microsoft enterprise healthcare channel is the structural threat on the broader healthcare-AI procurement budget. |
| Healthcare RPA (UiPath Healthcare, Olive AI before wind-down) | Horizontal RPA platforms applied to healthcare back-office automation; UiPath Healthcare is the principal live representative after Olive AI wound down in October 2023. | Horizontal-RPA channel and reseller network applied to healthcare-vertical use cases; less healthcare-specific procurement depth than Notable’s direct ambulatory-care motion. | Medium — horizontal RPA platforms competing on the staff-workflow automation surface Notable anchors; less healthcare-vertical-specific than Notable but credible flanking risk on enterprise healthcare-automation procurement. |
| Epic / Oracle Health native automation ((Epic and Oracle Health)) |
Native AI workflow automation shipped inside the Epic EHR (43.7% acute-care share per KLAS 2024) and Oracle Health’s post-Cerner stack; positioned as the in-platform default for automation surfaces. | Inside every Epic and Oracle Health deployment by default; bundled into existing EHR enterprise contracts and the principal substitution risk on the EHR-native automation trajectory. | Medium-high — EHR-native flank — Epic’s growing native AI workflow capabilities (at 43.7% acute-care market share per KLAS 2024 data) and Oracle Health’s automation tooling compete on the EHR-integrated automation surface. The bull case is that Notable’s Oracle Validated Integration and Epic deployment depth is the structural moat; the bear case is that EHR-native automation compresses the third-party automation lane. |
Potential Risks
Adjacent-category competitive pressure from ambient-scribe leaders
Abridge and Ambience are the healthcare-AI ambient-scribe category leaders, with materially larger valuations and broader investor coverage than Notable’s $600M Series B framing. The bull case is that Notable’s patient-engagement-and-staff-workflow positioning is structurally adjacent rather than substitutive to ambient-scribe and that the customer-base depth and EHR-integration moat is durable; the bear case is that Abridge and Ambience expand into the patient-engagement-and-staff-workflow surface from the ambient-scribe anchor, compressing Notable’s procurement budget.
Series B valuation framing and time-to-next-round
The November 2021 ICONIQ-Growth-led $100M Series B at $600M valuation is the most-recent priced round on the public record at time of writing. The bull case is that the 12,000+ sites-of-care, 32M+ patients and 1.4M+ tasks-daily customer base and the Flow AI / Flow Builder product cycle support a subsequent priced round at a higher valuation; the bear case is that no new priced round has been publicly disclosed and that the time-to-next-round trajectory is a watched commercial variable through 2026.
Foundation-model supplier exposure on Flow AI
Notable’s Flow AI conversational assistant routes across multiple foundation-model providers. The bull case is that the multi-model architecture is the moat against any single supplier substitution; the bear case is that capability shifts at the model-provider tier — including hyperscaler / model-provider healthcare-AI native offerings — propagate directly into Notable’s product capability.
EHR-native automation flanking risk
Epic at 43.7% acute-care EHR market share per KLAS 2024 data plus Oracle Health are building native AI workflow automation capabilities. The bull case is that Notable’s Oracle Validated Integration and Epic deployment depth is the structural moat that lets Notable run alongside EHR-native automation; the bear case is that EHR-native automation compresses the third-party automation lane over time.
Regulatory exposure — HIPAA and AI-specific regulatory cadence
Notable operates under HIPAA, the FDA AI/ML-as-medical-device regulatory cadence and state-level health-data regulatory regimes (California CMIA, Texas HSC etc.). The bull case is that healthcare-vertical specialism forces compliance discipline that horizontal RPA platforms cannot match; the bear case is that any compliance incident at a marquee customer is a brand-defining event in healthcare-AI procurement.
Recent IM Coverage
- Healthcare AI sector landing page Jun 2026.
- AI Tracker methodology Jun 2026.
Show recent press coverage of Notable Health
- Nov 2021 — Notable Raises Series B to Expand Intelligent Automation in Healthcare. (Notable Health Blog)
- Nov 2021 — Notable, which makes RPA-based tools to speed up healthcare admin, raises $100M at a $600M valuation. (TechCrunch)
- 2025 — Notable Launches Flow AI: A Conversational Assistant to Accelerate Workflow Automation in Healthcare. (Notable Health Blog)
- 2025 — Notable unveils next-generation of Flow Builder, expanding AI-powered automation in healthcare. (Notable Health Blog)
- 2025 — Notable and CityMD announce multi-year partnership to transform patient access with AI and automation. (Notable Health Blog)
- 2025 — Notable achieves Oracle Validated Integration with Oracle Health Expertise. (Notable Health Blog)
- 2025 — MUSC Health doubles down on patient access transformation with Notable. (Notable Health Blog)
Show the source register for the figures on this page
IM operates a primary-source-where-possible discipline. The figures above come from:
- Revenue (basis-disclosure note): Notable Health does not separately disclose ARR or revenue in primary sources at time of writing. The November 2021 Series B announcement is the most-recent material commercial-trajectory disclosure. We decline-to-publish a precise revenue figure pending a primary disclosure.
- Sites of care: Notable Health is deployed at 12,000+ sites of care automating 1.4M+ tasks daily across scheduling, registration, intake, referrals and prior authorizations. Named customer references include Intermountain Health, Medical University of South Carolina (MUSC), North Kansas City Hospital and CityMD per the company’s own coverage.
- Headcount (basis-disclosure note): Notable Health is private and does not separately publish headcount in primary sources at time of writing. The company’s careers page is the canonical entry point. We decline-to-publish a precise headcount figure.
- Funding to date: Cumulative external capital approximately $120M+ across multiple rounds through the November 2021 $100M Series B at $600M valuation led by ICONIQ Growth with Greylock, F-Prime Capital, Oak HC/FT, Maverick Ventures and 8VC participating per TechCrunch coverage. No new priced round has been publicly disclosed at time of writing post the November 2021 Series B.
Methodology & Disclaimer
For metric definitions, source-tier hierarchy, and decline-to-publish rules, see the tracker methodology. Confidence dots (• green / • amber / • red) follow the same convention as the AI Tracker.
Spotted a figure you believe is wrong? Send corrections to info@informationmatters.net.
Information Matters Framework scores are the considered opinion of the IM team — human and AI — applied to publicly-available evidence under a disclosed methodology. They are not statements of fact about the companies scored and they are not investment advice.
